Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis
Keywords:
Materias Investigacion::Ciencias de la Salud::Oncología
Publisher:
American Association for Cancer Research
Citation:
Gonzalez I, Andreu EJ, Panizo A, Inoges S, Fontalba A, Fernandez-Luna J, et al. Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis. Clin cancer res. 2004, Jan;10:751–761.
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.